Latent inhibition as a function of positive and negative schizotypal symptoms: Evidence for a bi-directional model

Personality and Individual Differences

Volumn 47, Issue 5, 2009, Pages 434-438

  Shrira, Amit ^a   Tsakanikos, Elias ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Latent inhibition; Negative symptoms; Positive symptoms; Schizotypy

Indexed keywords

EID: 67349086021     PISSN: 01918869     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paid.2009.04.015     Document Type: Article

References (45)

1. Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. International Journal of Neuropsychopharmacology 7 (2004) S1-S5
2. Anscombe R. The disorder of consciousness in schizophrenia. Schizophrenia Bulletin 13 (1987) 241-260
3. Bentall R.P., Claridge G.S., and Slade P.D. The multidimensional nature of schizotypal traits: A factor analytic study with normal subjects. British Journal of Clinical Psychology 28 (1989) 363-375
4. Bradbury D.A., Stirling J., Cavill J., and Parker A. Psychosis-like experiences in the general population: An exploratory factor analysis. Personality and Individual Differences 46 (2009) 729-734
5. Braff D.L. Information processing and attention dysfunctions in schizophrenia. Schizophrenia Bulletin 19 (1993) 233-259
6. Braunstein-Bercovitz H. Is the attentional dysfunction in schizotypy related to anxiety?. Schizophrenia Research 46 (2000) 255-267
7. Braunstein-Bercovitz H., and Lubow R.E. Are high-schizotypal normal participants distractible or limited in attentional resources? A study of latent inhibition as a function of masking task load and schizotypy level. Journal of Abnormal Psychology 107 (1998) 659-670
8. Braunstein-Bercovitz H., Rammsayer T., Gibbons H., and Lubow R.E. Latent inhibition deficits in high-schizotypal normals: Symptom-specific or anxiety-related?. Schizophrenia Research 53 (2002) 109-121
9. Burch G.St.J., Hemsley D.R., and Joseph M.H. Trials-to-criterion latent inhibition in humans as a function of stimulus pre-exposure and positive-schizotypy. British Journal of Psychology 95 (2004) 179-196
10. Cohen E., Sereni N., Kaplan O., Weizman A., Kikinzon L., Weiner I., et al. The relation between latent inhibition and symptom-types in young schizophrenics. Behavioural Brain Research 149 (2004) 113-122
11. Crow T.J. Molecular pathology of schizophrenia: More than one disease process. British Medical Journal 280 (1980) 66-68
12. Dinn W.M., Harris C.L., Aycicegi A., Greene P., and Andover M.S. Positive and negative schizotypy in a student sample: Neurocognitive and clinical correlates. Schizophrenia Research 56 (2002) 171-185
13. Evans L.H., Gray N.S., and Snowden R.J. A new continuous within-participants latent inhibition task: Examining associations with schizotypy dimensions, smoking status and gender. Biological Psychology 74 (2007) 365-373
14. Eysenck H.J., and Eysenck S.B.G. Psychoticism as a dimension of personality (1976), Hodder and Stoughton, London
15. Gray J.A. Integrating schizophrenia. Schizophrenia Bulletin 24 (1998) 249-266
16. Gray N.S., Fernandez M., Williams J., Ruddle R.A., and Snowden R.J. Which schizotypal dimensions abolish latent inhibition?. British Journal of Clinical Psychology 41 (2002) 271-284
17. Kumari V., Cotter P.A., Mulligan O.F., Checkley S.A., Gray N.S., Hemsley D.R., et al. Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers. Journal of Psychopharmacology 13 (1999) 398-405
18. Langdon R., and Coltheart M. Mentalizing, schizotypy, and schizophrenia. Cognition 71 (1999) 43-71
19. Laruelle M., Abi-Dargham A., Gil R., Kegeles L., and Innis R. Increased dopamine transmission in schizophrenia: Relationship to illness phases. Biological Psychiatry 46 (1999) 56-72
20. Leumann L., Feldon J., Vollenweider F.X., and Ludewig K. Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biological Psychiatry 52 (2002) 729-739
21. Lewandowski K.E., Barrantes-Vidal N., Nelson-Gray R.O., Clancy C., Kepley H.O., and Kwapil T.R. Anxiety and depression symptoms in psychometrically identified schizotypy. Schizophrenia Research 83 (2006) 225-235
22. Lubow R.E. Latent inhibition and conditioned attention theory (1989), Cambridge University Press, New York
23. Lubow R.E. Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophrenia Bulletin 31 (2005) 139-153
24. Lubow R.E., and De la Casa G. Latent inhibition as a function of schizotypality and gender: Implications for schizophrenia. Biological Psychology 59 (2002) 69-86
25. Lubow R.E., and Gewirtz J. Latent inhibition in humans: Data, theory and implications for schizophrenia. Psychological Bulletin 117 (1995) 87-103
26. Lubow R.E., Kaplan O., and De la Casa G. Performance on the visual search analog of latent inhibition is modulated by an interaction between schizotypy and gender. Schizophrenia Research 52 (2001) 275-287
27. Lubow R.E., Weiner I., Schlossberg A., and Baruch I. Latent inhibition and schizophrenia. Bulletin of the Psychonomic Society 25 (1987) 464-467
28. Mason O., and Claridge G. The Oxford-Liverpool inventory of feelings and experiences (O-LIFE): Further description and extended norms. Schizophrenia Research 82 (2006) 203-211
29. Mason O., Claridge G., and Jackson M. New scales for the assessment of schizotypy. Personality and Individual Differences 18 (1995) 7-13
30. McCartan D., Bell R., Green J.F., Campbell C., Trimble K., Pickering A., et al. The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers. Journal of Psychopharmacology 15 (2001) 96-104
31. Raine A. The SPQ: A scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 17 (1991) 555-564
32. Raine A. Sex differences in schizotypal personality in a non-clinical population. Journal of Abnormal Psychology 101 (1992) 361-364
33. Raine A., Reynolds C., Lencz T., Scerbo A., Triphon N., and Kim D. Cognitive-perceptual, interpersonal and disorganized features of schizotypal personality. Schizophrenia Bulletin 20 (1994) 191-201
34. Rascle C., Mazas O., Vaiva G., Tournant M., Raybois O., Goudemond N., et al. Clinical features of latent inhibition in schizophrenia. Schizophrenia Research 51 (2001) 149-161
35. Rawlings D., and Goldberg M. Correlating a measure of sustained attention with a multi-dimensional measure of schizotypal traits. Personality and Individual Differences 31 (2001) 421-431
36. Rawlings D., Williams B., Haslam N., and Claridge G. Taxometric analysis supports a dimensional latent structure for schizotypy. Personality and Individual Differences 44 (2008) 1640-1651
37. Reynolds C.A., Raine A., Mellingen K., Venables P.J., and Mednick S.A. Three factor model of schizotypal personality: Invariance across culture, gender, religious affiliation, family adversity, and psychopathology. Schizophrenia Bulletin 26 (2000) 603-618
38. Serra A.M., Jones S.H., Toone B., and Gray J.A. Impaired associative learning in chronic schizophrenics and their first-degree relatives: A study of latent inhibition and the Kamin blocking effect. Schizophrenia Research 48 (2001) 273-289
39. Steel C., Hemsley D.R., and Jones S. 'Cognitive inhibition' and schizotypy as measured by the Oxford-Liverpool inventory of feeling and experiences. Personality and Individual Differences 20 (1996) 769-773
40. Swerdlow N.R., Stephany N., Wasserman L.C., Talledo J., Sharp R., and Auerbach P.P. Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm. Psychopharmacology 169 (2003) 314-320
41. Tsakanikos E., and Reed P. Visuo-spatial processing and dimensions of schizotypy: Figure-ground segregation as a function of psychotic-like features. Personality and Individual Differences 35 (2003) 703-712
42. Tsakanikos E., and Reed P. Latent inhibition and context change in psychometrically defined schizotypy. Personality and Individual Differences 36 (2004) 1827-1839
43. Tsakanikos E., and Reed P. Do positive schizotypal symptoms predict false perceptual experiences in nonclinical populations?. Journal of Nervous and Mental Disease 193 (2005) 809-812
44. Vaitl D., Lipp O., Bauer U., Schuler G., Stark R., Zimmermann M., et al. Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. Schizophrenia Research 55 (2002) 147-158
45. Weiner I. The 'two-headed' latent inhibition model of schizophrenia: Modeling positive and negative symptoms and their treatment. Psychopharmacology 169 (2003) 257-297